Do serum angiopoietin-1, angiopoietin-2, and their receptor tie-2 and 4g/5g variant of pai-1 gene have a role in the pathogenesis of preeclampsia?

Journal of Investigative Medicine

Volumn 59, Issue 7, 2011, Pages 1147-1150

  Kamal, Manal ^a   El Khayat, Waleed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Angiopoietins; PAI 1; Polymorphism; Preeclampsia; Tie 2

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANT WOMAN; SERUM;

EID: 84856757515     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31822c5bdf     Document Type: Article

References (21)

1. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull. 2003;67:161-176. (Pubitemid 38111999)
2. Cohen A, Lim KH, Lee Y, et al. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase1 are elevated in women with pregestational diabetes and preeclampsia angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care. 2007;30(2):375.
3. Caron C, Goudemand J, Marey A, et al. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost. 1991;66:410-414.
4. Estelles A, Gilabert J, Keeton M, et al. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood. 1994;84:143-150. (Pubitemid 24193815)
5. Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal. Arch Gynecol Obstet. 2006;273(6):322-324.
6. Fabbro D, D'Elia AV, Spizzo R, et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest. 2003;56(1):17-22. (Pubitemid 37025942)
7. Ye S, Green FR, Scarabin PY, et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 1995;74:837-841.
8. Kathiresan S, Gabriel SB, Yang Q, et al. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels. Circulation. 2005;112:1728-1735. (Pubitemid 41368148)
9. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594. (Pubitemid 40807500)
10. Falk G, Svensson H, Almqvist A , et al. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis. 1994;8(suppl 1):45-47.
11. Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008;18(5-24):186-194.
12. Seval Y, Sati L, Celik-Ozenci C, et al. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta. 2008;29(9):809-815.
13. Zygmunt M, Herr F, Münstedt K, et al. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2003;22(110) (suppl 1):S10-S18. (Pubitemid 37074857)
14. Nadar SK, Karalis I, Al Yemeni E, et al. Plasma markers of angiogenesis in pregnancy induced hypertension. Thromb Haemost. 2005;94(5): 1071-1076. (Pubitemid 41645951)
15. Vuorela P, Matikainen MT, Kuusela P, et al. Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet Gynecol. 1998;92:179-183. (Pubitemid 28350844)
16. Hirokoshi K, Maeshima Y, Kobayashi K, et al. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Am J Hypertens. 2005;18:1181-1188. (Pubitemid 41337970)
17. Bolin M, Wiberg-Itzel E, Wikström AK, et al. Angiopoietin-1/ angiopoietin-2 ratio for prediction of preeclampsia. Am J Hypertens. 2009;22(8):891-895.
18. Gotsch F, Romero R, Kusanovic JP, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med. 2008;21(6):389-402. (Pubitemid 351999171)
19. Yamada N, Arinami T, Yamakawa-Kobayashi K, et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet. 2000; 45(3):138-141. (Pubitemid 30324115)
20. Kobashi G, Ohta K, Yamada H, et al. 4G/5G Variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase. J Epidemiol. 2009;19(6):275-280.
21. Festa A, D'Agostino R, Rich SS, et al. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in Blacks, Hispanics and Non-Hispanics and non-Hispanic Whites. The insulin resistance atherosclerosis study. Circulation. 2003;107:2422.